Low-molecular-weight heparins for the prevention of recurrent venous thromboembolism in patients with cancer: A systematic literature review of efficacy and cost-effectiveness

por Dranitsaris, George, Shane, Lesley G, Woodruff, Seth
Publicado 2017

Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis

por Dranitsaris, George, Shane, Lesley G, Crowther, Mark, Feugere, Guillaume, Woodruff, Seth
Publicado 2017

Assessing the Value of Biosimilars: A Review of the Role of Budget Impact Analysis

por Simoens, Steven, Jacobs, Ira, Popovian, Robert, Isakov, Leah, Shane, Lesley G.
Publicado 2017

Drug tendering: drug supply and shortage implications for the uptake of biosimilars

por Dranitsaris, George, Jacobs, Ira, Kirchhoff, Carol, Popovian, Robert, Shane, Lesley G
Publicado 2017

Patient attitudes and understanding about biosimilars: an international cross-sectional survey

por Jacobs, Ira, Singh, Ena, Sewell, K Lea, AL-Sabbagh, Ahmad, Shane, Lesley G
Publicado 2016

Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published Evidence

por Jacobs, Ira, Petersel, Danielle, Shane, Lesley G., Ng, Chee-Keng, Kirchhoff, Carol, Finch, Gregory, Lula, Sadiq
Publicado 2016